PAUL K. NEUMANN PROFESSORSHIP IN PANCREATIC CANCER
Established in 1998 by Mark D. and Robin B. Neumann in memory of Mr. Neumann's father

PAUL K. NEUMANN, who was president of PKN Commercial Real Estate in Baltimore, was diagnosed with pancreatic cancer in 1987. Although he died in 1992 when his cancer returned, Mr. Neumann benefited from the care he received from John L. Cameron, the Alfred Blalock Distinguished Service Professor of Surgery, who for 19 years served as the chief of surgery at The Johns Hopkins Hospital.

 

"My family feels that Dr. Cameron bought us five good years with Dad that we wouldn't have had otherwise," said MARK D. NEUMANN, who, with his wife ROBIN B. NEUMANN, made this professorship possible. Mark Neumann is an entrepreneur and a general partner of Nobska Ventures. He was previously a partner in B & N Ventures and president and co-founder of Special Counsel, the nation's largest legal staffing company.

This professorship will support a prominent surgeon in his or her efforts to determine the causes of, prevention strategies for, and management options for pancreatic cancer.

 

STEVEN D. LEACH, the first Paul K. Neumann Professor in Pancreatic Cancer, joined the faculty in the Department of Surgery in 2000, and became chief of the Division of Surgical Oncology in 2001. Dr. Leach has published extensively on the diagnosis, treatment and staging of pancreatic cancer. He has identified important links between mechanisms regulating normal pancreatic development and the initiation of human pancreatic cancer. "I have become convinced," Dr. Leach says, "that the only way to win the war against pancreatic cancer is to prevent it from ever getting started. Our laboratory is focused on the earliest form of pancreatic cancer, and is performing studies to identify the 'cell of origin' for this disease." In addition to his research activities, Dr. Leach serves on the graduate faculty in the Cellular and Molecular Medicine Program and actively participates in the clinical and scientific training of students and residents. His recent initiatives include organizing and chairing an international NCI-sponsored symposium on mouse models of pancreatic cancer. He has served on several NIH study sections, as well as the recent NIH Pancreatic Cancer Progress Review Group.